Viking Therapeutics, Inc. — Form D
Viking Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-22. The offering totals $3.7M. Industry: Biotechnology.
Offering
- Filed: 2017-06-22
- Form: D
- Accession: 0001607678-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.7M
- Remaining: $3.7M
- Investors: 10
- Date of first sale: 2017-06-19
- Revenue range: No Revenues
- SEC file number: 021-289294
Issuer
- Name: Viking Therapeutics, Inc.
- CIK: 0001607678
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 12340 EL CAMINO REAL, SUITE 250, SAN DIEGO, CA, 92130
- Phone: 858-704-4660
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Matthew W Foehr | Director | Emeryville, CA |
| Brian Lian | Director | New York, NY |
| Lawson Macartney | Director | San Diego, CA |
| J. Matthew Singleton | Director | San Diego, CA |
| Stephen W Webster | Director | San Diego, CA |
| Brian Lian | Executive Officer | New York, NY |
| Michael Morneau | Executive Officer | San Diego, CA |
More